Felicia Williams - 01 Jun 2025 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
01 Jun 2025
Net transactions value
$0
Form type
4
Filing time
03 Jun 2025, 16:08:31 UTC
Previous filing
08 May 2025
Next filing
09 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Williams Felicia Director 9490 NEOGENOMICS WAY, FORT MYERS /s/ Ali Olivo, Attorney-in-Fact 03 Jun 2025 0001675737

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Options Exercise $0 +7,160 $0.000000 7,160 01 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Restricted Stock Unit Options Exercise $0 -7,160 -100% $0.000000 0 01 Jun 2025 Common Stock 7,160 $0.000000 Direct F2
transaction NEO Stock Option (Right to Buy) Award $0 +16,107 $0.000000 16,107 01 Jun 2025 Common Stock 16,107 $7.28 Direct
transaction NEO Restricted Stock Unit Award $0 +23,077 $0.000000 23,077 01 Jun 2025 Common Stock 23,077 $0.000000 Direct F2
holding NEO Stock Option (Right to Buy) 5,430 01 Jun 2025 Common Stock 5,430 $13.59 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects release of restricted stock units that were previously reported on a Form 4.
F2 Once vested, the shares of common stock are not subject to expiration.